Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Neus Ferrer-Miralles

Showing results (61-70 of 90) with videos related to

Pageof 9
Sort By:
Nanotechnology|November 29, 2016
Engineering tumor cell targeting in nanoscale amyloidal materialsUgutz Unzueta, Joaquin Seras-Franzoso, María Virtudes Céspedes, et al.
Microbial Cell Factories|October 8, 2016
Functional inclusion bodies produced in the yeast Pichia pastorisFabián Rueda, Brigitte Gasser, Alejandro Sánchez-Chardi, et al.
Nanomedicine (London, England)|February 13, 2010
Protein nanodisk assembling and intracellular trafficking powered by an arginine-rich (R9) peptideEsther Vazquez, Mónica Roldán, César Diez-Gil, et al.
FEMS Microbiology Reviews|October 26, 2018
Bacterial inclusion bodies are industrially exploitable amyloidsArio de Marco, Neus Ferrer-Miralles, Elena Garcia-Fruitós, et al.
Pharmaceutics|March 26, 2022
The Poly-Histidine Tag H6 Mediates Structural and Functional Properties of Disintegrating, Protein-Releasing Inclusion BodiesJulieta María Sánchez, José Vicente Carratalá, Naroa Serna, et al.
Cancer Research|August 3, 2002
The N-ras proto-oncogene can suppress the malignant phenotype in the presence or absence of its oncogeneRoberto Diaz, Daniel Ahn, Lluis Lopez-Barcons, et al.
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|May 13, 2026
Recombinant Protein Drugs: A 2025 UpdateHèctor López-Laguna, Eloi Parladé, Marianna T P Favaro, et al.
Nanomedicine : Nanotechnology, Biology, and Medicine|March 8, 2016
Rational engineering of single-chain polypeptides into protein-only, BBB-targeted nanoparticlesNaroa Serna, María Virtudes Céspedes, Paolo Saccardo, et al.
Nanoscale|May 3, 2017
Intrinsic functional and architectonic heterogeneity of tumor-targeted protein nanoparticlesMireia Pesarrodona, Eva Crosas, Rafael Cubarsi, et al.
New Biotechnology|February 7, 2020
Aggregation-prone peptides modulate activity of bovine interferon gamma released from naturally occurring protein nanoparticlesJosé Vicente Carratalá, Olivia Cano-Garrido, Julieta Sánchez, et al.
Pageof 9

Showing results (61-70 of 90) with videos related to

Sort By:
Pageof 9
Nanotechnology|November 29, 2016
Engineering tumor cell targeting in nanoscale amyloidal materialsUgutz Unzueta, Joaquin Seras-Franzoso, María Virtudes Céspedes, et al.
Microbial Cell Factories|October 8, 2016
Functional inclusion bodies produced in the yeast Pichia pastorisFabián Rueda, Brigitte Gasser, Alejandro Sánchez-Chardi, et al.
Nanomedicine (London, England)|February 13, 2010
Protein nanodisk assembling and intracellular trafficking powered by an arginine-rich (R9) peptideEsther Vazquez, Mónica Roldán, César Diez-Gil, et al.
FEMS Microbiology Reviews|October 26, 2018
Bacterial inclusion bodies are industrially exploitable amyloidsArio de Marco, Neus Ferrer-Miralles, Elena Garcia-Fruitós, et al.
Pharmaceutics|March 26, 2022
The Poly-Histidine Tag H6 Mediates Structural and Functional Properties of Disintegrating, Protein-Releasing Inclusion BodiesJulieta María Sánchez, José Vicente Carratalá, Naroa Serna, et al.
Cancer Research|August 3, 2002
The N-ras proto-oncogene can suppress the malignant phenotype in the presence or absence of its oncogeneRoberto Diaz, Daniel Ahn, Lluis Lopez-Barcons, et al.
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|May 13, 2026
Recombinant Protein Drugs: A 2025 UpdateHèctor López-Laguna, Eloi Parladé, Marianna T P Favaro, et al.
Nanomedicine : Nanotechnology, Biology, and Medicine|March 8, 2016
Rational engineering of single-chain polypeptides into protein-only, BBB-targeted nanoparticlesNaroa Serna, María Virtudes Céspedes, Paolo Saccardo, et al.
Nanoscale|May 3, 2017
Intrinsic functional and architectonic heterogeneity of tumor-targeted protein nanoparticlesMireia Pesarrodona, Eva Crosas, Rafael Cubarsi, et al.
New Biotechnology|February 7, 2020
Aggregation-prone peptides modulate activity of bovine interferon gamma released from naturally occurring protein nanoparticlesJosé Vicente Carratalá, Olivia Cano-Garrido, Julieta Sánchez, et al.
Pageof 9